Mark Danton
Corporate Officer/Principal at AC IMMUNE SA
Network origin in Mark Danton first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
27
| Public Company | Pharmaceuticals: Major | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Danton via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Doctorate Degree | |
| BIOMÉRIEUX | Medical Specialties | Director of Finance/CFO | |
| University of Tilburg | College/University | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Milan | College/University | Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Bern | College/University | Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree | |
| Medical College of Virginia | College/University | Doctorate Degree | |
Pantec Biosolutions AG
 Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Drugstore Chains | Director/Board Member | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
| NOVIMMUNE SA | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder Founder | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | ||
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Chairman | |
Evotec (Hamburg) GmbH
 Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Miscellaneous Commercial Services | Chief Executive Officer | |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| Switzerland | 25 |
| Germany | 8 |
| United States | 6 |
| France | 4 |
| Netherlands | 4 |
Sectoral
| Health Technology | 14 |
| Consumer Services | 14 |
| Finance | 4 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 107 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 27 |
| Chairman | 25 |
| Chief Tech/Sci/R&D Officer | 21 |
Most connected contacts
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Alan Colowick | 30 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Werner Lanthaler | 13 |
| Andrea Pfeifer | 11 |
| Thomas Graney | 11 |
| Carl June | 9 |
| Gary Waanders | 8 |
| Monica Shaw | 8 |
| Marie Kosco-Vilbois | 7 |
| Sonia Maria Poli | 7 |
| Roy Ervin Twyman | 6 |
| Julien Rongère | 5 |
- Stock Market
- Insiders
- Mark Danton
- Company connections
